Breakthrough Standards for Evaluating Aging Biomarkers Introduced
Groundbreaking Research on Aging Biomarkers A team of Harvard researchers, led by aging and longevity expert Alex Zhavoronkov, PhD, has published a groundbreaking paper in Nature Medicine outlining new standards for evaluating biomarkers of aging. Biomarkers, which are biological characteristics used to measure various biological processes, including disease progression and treatment response, have lacked standardization in assessing aging-related changes. The study aims to address this gap by providing a framework for developing and validating aging biomarkers to predict longevity and overall quality of life. Standardization Efforts and Clinical Tools The research team analyzed omic data from population-based studies to identify blood-based biomarkers of aging. Omic data encompass biological molecules such as proteins, transcripts, genes, and epigenetic factors. By comparing different biomarkers and study designs, the researchers sought to establish standardized approaches for evalua...